On ECHEMI
Home > Drugs > Budd-Chiari syndrome
Budd-Chiari syndrome
Budd-Chiari Syndrome is a syndrome with liver blood drainage disorder as the main manifestation caused by partial or complete obstruction of the hepatic vein or inferior vena cava, also known as hepatic venous obstruction syndrome. This syndrome was reported by Budd and Chiari in 1846 and 1889 respectively. The main clinical features are abdominal pain, hepatosplenomegaly, ascites and lower limb edema. This syndrome is relatively rare and can be seen at any age, but most cases are between 20 and 40 years old.
  • Site of disease:

    liver
  • Infectious :

    Not contagious
  • Frequent population:

    20-40 years old, male to female ratio is 1.2/1 to 2/1
  • Related symptoms:

    Stomach ache ulcer oliguria ascites varicose veins
  • Concurrent disease:

Related Drugs
Bifendate Tablets
Indication: This product has a certain effect on the improvement of the main symptoms of hepatitis such as liver pain, fatigue, abdominal distension, etc., but it is ineffective for changes in hepatosplenomegaly. It is suitable for patients with persistent hepatitis and long-term single alanine aminotransferase abnormalities.
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Ganpikang Capsule
Manufacturer:

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Zhuzigantai Capsule
Manufacturer:

Xishuangbanna Banna Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.